{"DataElement":{"publicId":"3909347","version":"1","preferredName":"Recurrent Disease Detection Cytogenetic Analysis Method Type","preferredDefinition":"A description of the cytogenetic assessment method used to detect disease relapse.","longName":"3909346v1.0:2861464v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3909346","version":"1","preferredName":"Recurrent Disease Detection Cytogenetic Analysis Method","preferredDefinition":"The return of a disease after a period of remission._The activity of perceiving, discerning, discovering or identifying._Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","longName":"3909343v1.0:2782517v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"4147492","version":"1","preferredName":"Recurrent Disease Detection","preferredDefinition":"The return of a disease after a period of remission.:The activity of perceiving, discerning, discovering or identifying.","longName":"C38155:C16210","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Detection","conceptCode":"C16210","definition":"The act of perceiving, discerning, discovering, or identifying.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F222B58E-CE01-B676-E040-BB89AD4323EE","latestVersionIndicator":"Yes","beginDate":"2014-02-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-02-11","modifiedBy":"ONEDATA","dateModified":"2014-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2782517","version":"1","preferredName":"Cytogenetic Analysis Method","preferredDefinition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.:A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","longName":"C18280:C71460","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Analysis","conceptCode":"C18280","definition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Method","conceptCode":"C71460","definition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"567BE225-9CFE-5DF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2008-09-09","modifiedBy":"ONEDATA","dateModified":"2008-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E75E3E14-0601-6EFF-E040-BB89AD4378E5","latestVersionIndicator":"Yes","beginDate":"2013-09-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-09-27","modifiedBy":"NYCHM","dateModified":"2017-02-28","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2861464","version":"1","preferredName":"Cytogenetic Analysis Method Type","preferredDefinition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal._Type; a subdivision of a particular kind of thing.","longName":"2861464v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Conventional cytogenetics","valueDescription":"Chromosome Banding","ValueMeaning":{"publicId":"2862254","version":"1","preferredName":"Chromosome Banding","longName":"2862254","preferredDefinition":"The treatment of chromosomes to reveal characteristic patterns of horizontal bands.  The banding patterns lend each chromosome a distinctive appearance so the 22 pairs of human nonsex chromosomes and the X and Y chromosomes can be identified and distinguished without ambiguity. Banding also permits the recognition of chromosome deletions (lost segments), chromosome duplications (surplus segments) and other types of structural rearrangements of chromosomes. (MedicineNet.com)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chromosome Banding","conceptCode":"C16437","definition":"The treatment of chromosomes to reveal characteristic patterns of horizontal bands.  The banding patterns lend each chromosome a distinctive appearance so the 22 pairs of human non-sex chromosomes and the X and Y chromosomes can be identified and distinguished without ambiguity. Banding also permits the recognition of chromosome deletions (lost segments), chromosome duplications (surplus segments) and other types of structural rearrangements of chromosomes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"682A552E-41E8-E53B-E040-BB89AD4350EB","latestVersionIndicator":"Yes","beginDate":"2009-04-22","endDate":null,"createdBy":"CZECHS","dateCreated":"2009-04-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"682A552E-4200-E53B-E040-BB89AD4350EB","beginDate":"2009-04-22","endDate":null,"createdBy":"CZECHS","dateCreated":"2009-04-22","modifiedBy":"ONEDATA","dateModified":"2009-04-22","deletedIndicator":"No"},{"value":"FISH","valueDescription":"Fluorescence in situ Hybridization","ValueMeaning":{"publicId":"2862253","version":"1","preferredName":"Fluorescence in situ Hybridization","longName":"2862253","preferredDefinition":"A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"682A552E-41C6-E53B-E040-BB89AD4350EB","latestVersionIndicator":"Yes","beginDate":"2009-04-22","endDate":null,"createdBy":"CZECHS","dateCreated":"2009-04-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B0618532-9E78-D5C5-E040-BB89AD431905","beginDate":"2009-04-22","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-10-28","modifiedBy":"ONEDATA","dateModified":"2011-10-28","deletedIndicator":"No"},{"value":"Karyotyping","valueDescription":"Karyotyping","ValueMeaning":{"publicId":"5095203","version":"1","preferredName":"Karyotyping","longName":"5095203","preferredDefinition":"The preparation, analysis, and interpretation of a karyotype, the representation of the chromosome set of a cell.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Karyotyping","conceptCode":"C16768","definition":"The preparation, analysis, and interpretation of a karyotype, the representation of the chromosome set of a cell.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"280CB7B5-C81B-43D4-E050-BB89AD4365A7","latestVersionIndicator":"Yes","beginDate":"2015-12-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"280CB7B5-C834-43D4-E050-BB89AD4365A7","beginDate":"2015-12-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-29","modifiedBy":"ONEDATA","dateModified":"2015-12-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3302918","version":"1","preferredName":"Cytogenetic Analysis Method Type","preferredDefinition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.:A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.:Type; a subdivision of a particular kind of thing.","longName":"C18280:C71460:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Analysis","conceptCode":"C18280","definition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Method","conceptCode":"C71460","definition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B150DC18-93FD-4A09-E040-BB89AD43627C","latestVersionIndicator":"Yes","beginDate":"2011-11-09","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-11-09","modifiedBy":"ONEDATA","dateModified":"2011-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67C29AD3-44CC-DC20-E040-BB89AD4301AC","latestVersionIndicator":"Yes","beginDate":"2009-04-17","endDate":null,"createdBy":"CZECHS","dateCreated":"2009-04-17","modifiedBy":"KUMMEROA","dateModified":"2015-12-29","changeDescription":". Corrected spelling in def. AK 11/314  Added PV \"karyotyping\" for 2450r4. AK 12/29/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What was the disease recurren","type":"Preferred Question Text","description":"What was the disease recurrence detection cytogenetic method?","url":null,"context":"NHLBI"},{"name":"What was the disease relapse detection cytogenetic testing method?","type":"Alternate Question Text","description":"What was the disease relapse detection cytogenetic testing method?","url":null,"context":"NHLBI"},{"name":"What was the cytogenetic disease relapse detection method?","type":"Alternate Question Text","description":"What was the cytogenetic disease relapse detection method?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E75E3E14-0617-6EFF-E040-BB89AD4378E5","latestVersionIndicator":"Yes","beginDate":"2013-09-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-09-27","modifiedBy":"NYCHM","dateModified":"2017-02-28","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}